Egyptian Drug Authority grants emergency license for Chinas CoronaVac

PHOTO

CAIRO: The Egyptian Drug Authority (EDA) has authorized the emergency use of China’s CoronaVac.

Mahmoud Yassin, who is the EDA’s head of Central Administration for Biological and Innovative Products, said Monday that the license was given after the vaccine had passed through the authority’s assessment and evaluation process while also following local and international rules to ensure the jab’s effectiveness and quality.

Emergency EDA licenses were previously granted to the Sinopharm, AstraZeneca, Sputnik V and AZD1222 vaccines.

Last week Egypt signed two agreements with China’s Sinovac allowing it to have local manufacturing rights.

The Russian Direct Investment Fund also announced an agreement with Egyptian firm Minapharm to produce more than 40 million doses of Sputnik V.

These steps are part of the government’s efforts to contain the COVID-19 outbreak and provide vaccines to everyone in Egypt.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.